
|Webinars|December 20, 2021
Success in Value-Based Contracting—Using Evidence, Technology, and Data to Improve Outcomes and Eliminate Low-Value Care, Part 1
Experts from Optum, WellMed, and Reliant discuss strategies for bringing value-based payment into specialty care through the use of education and analytics.
Advertisement
In the latest Matters in Managed Care webinar, experts discussed how to improve outcomes and eliminate low-value care. They defined actions and practices that constitute wasted and harmful care, described how to rapidly translate high-quality evidence-based medicine into daily practice, recognized how to leverage technology, and more.
Ken Cohen, MD, FACP, senior medical director and executive director, clinical research national senior medicaldirector, Optum Care, moderated the panel with:
- Troy Comstock, MD, regional medical director, Florida WellMed Medical Management
- Dan Murrey, MD, MPP, chief medical officer, surgical care associates; president, OptumCare Specialty Practices
- Thad Schilling, MD, chief medical officer, Reliant Medical Group
In segment 1, they discussed using education to drive transformation.
Advertisement
Related to this article

In this part 2, Kirsten Axelsen, MS, discusses racial disparities, AI in prior authorization, and payers’ readiness for the next wave of CLL therapies.

Kirsten Axelsen, MS, discusses gaps in biomarker testing, nonmedical barriers, and utilization management from a new report on access to CLL care.

In this Q&A, Christie Ballantyne, MD, explains why consistent LDL-C lowering with oral enlicitide could expand PCSK9 use in primary prevention.

AHIP's Jeanette Thornton explains where 2027 prior authorization standards fit in the affordability debate and what plans want from Congress.

Earlier Alzheimer disease detection is outpacing specialist capacity and may widen gaps for underserved patients, Cleveland experts say.
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Dexmedetomidine Sublingual Film as At-Home Agitation Therapy
2
ObesityWeek 2026: Studies Map GLP-1 Access Gaps, Obesity's Costs
3
FDA Approves Weekly Gefurulimab for Generalized Myasthenia Gravis
4
Nondrug Therapies Ease Cough in Lung Cancer, Pulmonary Rehab Leads Pack
5

